难治性肺炎支原体肺炎感染患儿的免疫功能状态分析

Abstract
Figure/Table
References (15)
Related Citation (3)

Download: PDF (0 KB) HTML (37 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore effect of immune function status on refractory Mycoplasma pneumonia in children. Methods 100 children with refractory Mycoplasma pneumonia from February 2014 to November 2016 were selected as experimental group;while 100 children with general Mycoplasma pneumonia were selected as control group.Levels of serum immunoglobulin,T lymphocyte subsets,complement and extrapulmonary manifestations of two groups were detected and compared by using flow cytometry and immunoturbidimetry.Results Levels of serum IgG,IgA,IgM in experimental group were obvious higher than control group(P＜0.05).Levels of serum CD3+,CD4+and CD4+/CD8+in the experimental group were obvious lower than control group(P＜0.05).There was no significant difference in the levels of CD8+and complement C3 and C4 between the two groups(P＞0.05).The incidence of xtrapulmonary manifestations such as cardiovascular,liver,digestive tract,skin and nervous system in experimental group was higher than that of the control group,and the difference was statistical significance(P＜0.05).Conclusion Severe immune dysfunction in children with refractory Mycoplasma pneumonia,the main features of immunoglobulin,T lymphocyte subsets and complement levels are closely related to the incidence of extrapulmonary symptoms.It is suggested that reasonable immunotherapy can help to improve the condition,relieve the symptoms and shorten the course of disease,and is worth to popularize in clinical.

Key words： Rrefractory Mycoplasma pneumonia Immunoglobulin T lymphocyte subsets Complement

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Shao-cun
	HUANG Li-na
	GUO Chu

Cite this article:

LI Shao-cun,HUANG Li-na,GUO Chu. Analysis of immune function status in children with refractory Mycoplasma pneumonia[J]. 中国当代医药, 2017, 24(7): 136-138.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I7/136

[1]	梅玉霞，蒋瑾瑾，蔡斌，等.儿童难治性支原体肺炎临床危险因素分析[J].临床儿科杂志，2014，32（12）：1138-1140.
[2]	衣楠玲，刘芳，李元，等.小儿难治性支原体肺炎免疫功能分析[J].中国生育健康杂志，2016，27（2）：159-160.
[3]	黄晓妹.降钙素原、C-反应蛋白、白细胞计数在小儿肺炎诊断中的实用价值分析[J].中国实验诊断学，2015，19（1）：53-55.
[4]	林洁，骆林胜，黄鹏，等.肺炎支原体感染与小儿咳嗽变异性哮喘的关系及大环内酯类药物治疗的效果分析[J].中华医院感染学杂志，2016，26（12）：2843-2845.
[5]	王红连，徐进.儿童难治性肺炎支原体肺炎危险因素及支原体耐药的相关性分析[J].临床肺科杂志，2016，21（4）：678-682.
[6]	张龙奕，何康铭，饶雪梅，等.匹多莫德辅助治疗小儿难治性支原体肺炎的疗效观察[J].临床肺科杂志，2016，21（11）：2021-2024.
[7]	冯孝强，高春燕.小儿难治性肺炎支原体肺炎免疫机制及治疗研究进展[J].临床合理用药杂志，2016，9（13）：174-176.
[8]	李小艳.难治性支原体肺炎的研究新进展[J].右江医学，2015，43（5）：633-636.
[9]	陈欣，赵涛，郭建光，等.难治性肺炎支原体肺炎的肺外表现及免疫状态的临床分析[J].临床肺科杂志，2015，20（12）：2186-2190.
[10]	黄雅.难治性支原体肺炎的肺外表现及免疫因子观察[J].临床医学工程，2014，21（8）：989-990.
[11]	周兰芝，牟丹丹，李婷婷，等.儿童难治性支原体肺炎的发病机制及治疗[J].中国妇幼保健，2016，31（8）：1786-1788.
[12]	郑杨.儿童难治性肺炎支原体肺炎的发病机制[J].中国医刊，2014，49（7）：1-3.
[13]	白丽亚，杨英伟.难治性肺炎支原体肺炎的发病机制与治疗进展[J].临床合理用药杂志，2014，7（28）：179-180.
[14]	杨会荣，刘建华，帅金凤，等.清热解毒方对难治性支原体肺炎患儿T淋巴亚群的影响[J].河北中医药学报，2014，29（1）：6-8.
[15]	邱丽筠，郭爱丽，朱薇薇，等.儿童肺炎支原体肺炎研究进展[J].中国当代医药，2014，21（23）：192-194.